These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 25883088)

  • 21. Structure-activity studies of a macrocyclic peptide inhibitor of histone lysine demethylase 4A.
    Passioura T; Bhushan B; Tumber A; Kawamura A; Suga H
    Bioorg Med Chem; 2018 Mar; 26(6):1225-1231. PubMed ID: 29402611
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bioluminescent High-Throughput Succinate Detection Method for Monitoring the Activity of JMJC Histone Demethylases and Fe(II)/2-Oxoglutarate-Dependent Dioxygenases.
    Alves J; Vidugiris G; Goueli SA; Zegzouti H
    SLAS Discov; 2018 Mar; 23(3):242-254. PubMed ID: 29239273
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of the histone demethylase KDM4A in cancer.
    Guerra-Calderas L; González-Barrios R; Herrera LA; Cantú de León D; Soto-Reyes E
    Cancer Genet; 2015 May; 208(5):215-24. PubMed ID: 25633974
    [TBL] [Abstract][Full Text] [Related]  

  • 24. C8-substituted pyrido[3,4-d]pyrimidin-4(3H)-ones: Studies towards the identification of potent, cell penetrant Jumonji C domain containing histone lysine demethylase 4 subfamily (KDM4) inhibitors, compound profiling in cell-based target engagement assays.
    Le Bihan YV; Lanigan RM; Atrash B; McLaughlin MG; Velupillai S; Malcolm AG; England KS; Ruda GF; Mok NY; Tumber A; Tomlin K; Saville H; Shehu E; McAndrew C; Carmichael L; Bennett JM; Jeganathan F; Eve P; Donovan A; Hayes A; Wood F; Raynaud FI; Fedorov O; Brennan PE; Burke R; van Montfort RLM; Rossanese OW; Blagg J; Bavetsias V
    Eur J Med Chem; 2019 Sep; 177():316-337. PubMed ID: 31158747
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design and discovery of new pyrimidine coupled nitrogen aromatic rings as chelating groups of JMJD3 inhibitors.
    Hu J; Wang X; Chen L; Huang M; Tang W; Zuo J; Liu YC; Shi Z; Liu R; Shen J; Xiong B
    Bioorg Med Chem Lett; 2016 Feb; 26(3):721-725. PubMed ID: 26776360
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of Jumonji demethylases reprograms severe dilated cardiomyopathy and prolongs survival.
    Tran TA; Zhang QJ; Wang L; Gonzales C; Girard L; May H; Gillette T; Liu ZP; Martinez ED
    J Biol Chem; 2022 Feb; 298(2):101515. PubMed ID: 34933013
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unravelling KDM4 histone demethylase inhibitors for cancer therapy.
    Baby S; Gurukkala Valapil D; Shankaraiah N
    Drug Discov Today; 2021 Aug; 26(8):1841-1856. PubMed ID: 34051367
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 4-Biphenylalanine- and 3-Phenyltyrosine-Derived Hydroxamic Acids as Inhibitors of the JumonjiC-Domain-Containing Histone Demethylase KDM4A.
    Morera L; Roatsch M; Fürst MC; Hoffmann I; Senger J; Hau M; Franz H; Schüle R; Heinrich MR; Jung M
    ChemMedChem; 2016 Sep; 11(18):2063-83. PubMed ID: 27505861
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of substrate-selective probes for affinity pulldown of histone demethylases.
    Marholz LJ; Chang L; Old WM; Wang X
    ACS Chem Biol; 2015 Jan; 10(1):129-37. PubMed ID: 25335116
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of small molecule inhibitors of Jumonji AT-rich interactive domain 1B (JARID1B) histone demethylase by a sensitive high throughput screen.
    Sayegh J; Cao J; Zou MR; Morales A; Blair LP; Norcia M; Hoyer D; Tackett AJ; Merkel JS; Yan Q
    J Biol Chem; 2013 Mar; 288(13):9408-17. PubMed ID: 23408432
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure-based design and discovery of potent and selective KDM5 inhibitors.
    Nie Z; Shi L; Lai C; O'Connell SM; Xu J; Stansfield RK; Hosfield DJ; Veal JM; Stafford JA
    Bioorg Med Chem Lett; 2018 May; 28(9):1490-1494. PubMed ID: 29627262
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The future therapeutic potential of histone demethylases: A critical analysis.
    Natoli G; Testa G; De Santa F
    Curr Opin Drug Discov Devel; 2009 Sep; 12(5):607-15. PubMed ID: 19736620
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Highly selective inhibition of histone demethylases by de novo macrocyclic peptides.
    Kawamura A; Münzel M; Kojima T; Yapp C; Bhushan B; Goto Y; Tumber A; Katoh T; King ON; Passioura T; Walport LJ; Hatch SB; Madden S; Müller S; Brennan PE; Chowdhury R; Hopkinson RJ; Suga H; Schofield CJ
    Nat Commun; 2017 Apr; 8():14773. PubMed ID: 28382930
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A scintillation proximity assay for histone demethylases.
    Yu W; Eram MS; Hajian T; Szykowska A; Burgess-Brown N; Vedadi M; Brown PJ
    Anal Biochem; 2014 Oct; 463():54-60. PubMed ID: 25010373
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Substituted 2-(2-aminopyrimidin-4-yl)pyridine-4-carboxylates as potent inhibitors of JumonjiC domain-containing histone demethylases.
    Roatsch M; Robaa D; Pippel M; Nettleship JE; Reddivari Y; Bird LE; Hoffmann I; Franz H; Owens RJ; Schüle R; Flaig R; Sippl W; Jung M
    Future Med Chem; 2016 Sep; 8(13):1553-71. PubMed ID: 26971619
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural definitions of Jumonji family demethylase selectivity.
    Pilka ES; James T; Lisztwan JH
    Drug Discov Today; 2015 Jun; 20(6):743-9. PubMed ID: 25555749
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening of inhibitors against histone demethylation jumonji domain-containing protein 3 by capillary electrophoresis.
    Zhang Y; Lou C; Xu Y; Li J; Qian S; Li F; Kang J
    J Chromatogr A; 2020 Feb; 1613():460625. PubMed ID: 31668999
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Screening for lysine-specific demethylase-1 inhibitors using a label-free high-throughput mass spectrometry assay.
    Plant M; Dineen T; Cheng A; Long AM; Chen H; Morgenstern KA
    Anal Biochem; 2011 Dec; 419(2):217-27. PubMed ID: 21855527
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Small molecule KDM4s inhibitors as anti-cancer agents.
    Lin H; Li Q; Li Q; Zhu J; Gu K; Jiang X; Hu Q; Feng F; Qu W; Chen Y; Sun H
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):777-793. PubMed ID: 29651880
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Temperature influences histone methylation and mRNA expression of the Jmj-C histone-demethylase orthologues during the early development of the oyster Crassostrea gigas.
    Fellous A; Favrel P; Riviere G
    Mar Genomics; 2015 Feb; 19():23-30. PubMed ID: 25224965
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.